YungShin Global Holding Corp
TWSE:3705
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.55
62.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
YungShin Global Holding Corp
Income from Continuing Operations
YungShin Global Holding Corp
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Income from Continuing Operations
NT$1.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Income from Continuing Operations
NT$95.3m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Income from Continuing Operations
NT$403m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Income from Continuing Operations
NT$138.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-4%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Income from Continuing Operations
NT$4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Income from Continuing Operations
NT$1.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
YungShin Global Holding Corp
Glance View
YungShin Global Holding Corp. engages in resources integration and business development. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-01-03. The firm mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The firm also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.
See Also
What is YungShin Global Holding Corp's Income from Continuing Operations?
Income from Continuing Operations
1.1B
TWD
Based on the financial report for Jun 30, 2024, YungShin Global Holding Corp's Income from Continuing Operations amounts to 1.1B TWD.
What is YungShin Global Holding Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
5%
Over the last year, the Income from Continuing Operations growth was 55%. The average annual Income from Continuing Operations growth rates for YungShin Global Holding Corp have been 17% over the past three years , 10% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
